Quantum Pharma promotes Chris Rigg to CFO

AIM-listed niche pharmaceutical manufacturer Quantum Pharma has promoted Chris Rigg to the role of chief financial officer.

The appointment follows the resignation of Martin Such on 7 March.

Rigg joined Quantum as the company’s strategic director in November 2015 and has been working as part of the senior management team reporting to the board on a broad range of group matters.

Prior to that, he was group corporate finance director at Eaga in 2009 and subsequently divisional managing director of the solar division.

After Eaga's acquisition by Carillion in 2011, he joined Barclays to head its North East large corporate banking division. Two years later, Rigg became chief executive of recruitment agency NRG.

Chief executive officer Andrew Scaife said: “Chris has a wealth of relevant experience in management, finance and strategic matters and, having joined the group last November, a good understanding of the group's businesses."

At 1240 GMT, Quantum shares were down 2.2% to 67.50p.